Phathom Pharmaceuticals (PHAT) Inventory (2023 - 2026)

Phathom Pharmaceuticals (PHAT) has 4 years of Inventory data on file, last reported at $6.5 million in Q1 2026.

• Inventory for Q1 2026 came in at $6.5 million, up 105.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.5 million (up 105.56% YoY), and the FY2025 annual result was $5.5 million, up 72.01% from the prior year.
• Inventory climbed to $6.5 million in Q1 2026 per PHAT's latest filing, from $5.5 million in the prior quarter.
• Over five years, Inventory peaked at $6.5 million in Q1 2026 and troughed at $111000.0 in Q2 2023.
• A 4-year average of $2.8 million and a median of $3.1 million in 2024 frame the typical range for Inventory.
• The sharpest annual moves came in 2024 and 2025: Inventory jumped 2702.7% in 2024, then increased 16.07% in 2025.
• A 4-year view of Inventory shows it stood at $1.2 million in 2023, then jumped by 165.56% to $3.2 million in 2024, then soared by 72.01% to $5.5 million in 2025, then grew by 17.94% to $6.5 million in 2026.
• Business Quant data shows PHAT's Inventory at $6.5 million in Q1 2026, $5.5 million in Q4 2025, and $3.6 million in Q3 2025.